P23443 (KS6B1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 127.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Ribosomal protein S6 kinase beta-1 Short name=S6K-beta-1 Short name=S6K1 EC=2.7.11.1 Alternative name(s): 70 kDa ribosomal protein S6 kinase 1 Short name=P70S6K1 Short name=p70-S6K 1 Ribosomal protein S6 kinase I Serine/threonine-protein kinase 14A p70 ribosomal S6 kinase alpha Short name=p70 S6 kinase alpha Short name=p70 S6K-alpha Short name=p70 S6KA | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 525 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the pre-initiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin. Ref.4 Ref.6 Ref.7 Ref.8 Ref.9 Ref.10 Ref.12 Ref.14 Ref.16 Ref.18 Ref.20 Ref.22 Ref.25 Ref.26 |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Enzyme regulation | Activation requires multiple phosphorylation events on serine/threonine residues. Activation appears to be first mediated by phosphorylation of multiple sites in the autoinhibitory domain, which facilitates phosphorylation at Thr-412, disrupting the autoinhibitory mechanism and allowing phosphorylation of Thr-252 by PDPK1. The active conformation of the kinase is believed to be stabilized by a mechanism involving three conserved phosphorylation sites located in the kinase domain activation loop (Thr-252) and in the AGC-kinase C-terminal domain (Ser-394 in the middle of the tail/linker region and Thr-412 within a hydrophobic motif at its end). Activated by mTORC1; isoform Alpha I and isoform Alpha II are sensitive to rapamycin, which inhibits activating phosphorylation at Thr-412. Activated by PDPK1. Ref.3 Ref.15 Ref.21 |
| Subunit structure | Interacts with PPP1R9A/neurabin-1 By similarity. Interacts with RPTOR. Interacts with IRS1. Interacts with EIF3B and EIF3C. Interacts with POLDIP3 and TRAF4. Ref.5 Ref.6 Ref.7 Ref.10 Ref.18 |
| Subcellular location | Cell junction › synapse › synaptosome By similarity. Mitochondrion outer membrane Ref.16 Ref.20. |
| Tissue specificity | Widely expressed. Ref.2 |
| Domain | The autoinhibitory domain is believed to block phosphorylation within the AGC-kinase C-terminal domain and the activation loop. The TOS (TOR signaling) motif is essential for activation by mTORC1 By similarity. |
| Post-translational modification | Phosphorylation at Thr-412 is regulated by mTORC1. The phosphorylation at this site is maintained by an agonist-dependent autophosphorylation mechanism By similarity. Activated by phosphorylation at Thr-252 by PDPK1. |
| Sequence similarities | Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. S6 kinase subfamily. Contains 1 AGC-kinase C-terminal domain. Contains 1 protein kinase domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| PPP2R2B | Q00005 | 2 | EBI-1775921,EBI-1052159 |
Alternative products
| This entry describes 2 isoforms produced by alternative initiation. [Align] [Select] Note: Additional isoforms seem to exist. | ||||||
| Isoform Alpha I (identifier: P23443-1) Also known as: p80-S6K 1; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform Alpha II (identifier: P23443-2) The sequence of this isoform differs from the canonical sequence as follows: 1-23: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 525 | 525 | Ribosomal protein S6 kinase beta-1 | PRO_0000024342 | |||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 91 – 352 | 262 | Protein kinase | ||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 353 – 423 | 71 | AGC-kinase C-terminal | ||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 97 – 105 | 9 | ATP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 424 – 525 | 102 | Autoinhibitory domain | ||||||||||||||||||||||||||||||||||||||||||||||||
| Motif | 28 – 32 | 5 | TOS motif | ||||||||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 218 | 1 | Proton acceptor By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 123 | 1 | ATP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 252 | 1 | Phosphothreonine; by PDPK1 Ref.3 Ref.29 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 304 | 1 | N6-acetyllysine Ref.24 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 394 | 1 | Phosphoserine Ref.20 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 412 | 1 | Phosphothreonine; by MTOR, NEK6 and NEK7 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 441 | 1 | Phosphoserine Ref.11 Ref.19 Ref.23 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 444 | 1 | Phosphothreonine Ref.11 Ref.19 Ref.20 Ref.23 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 447 | 1 | Phosphoserine Ref.11 Ref.13 Ref.19 Ref.20 Ref.23 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 516 | 1 | N6-acetyllysine By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 23 | 23 | Missing in isoform Alpha II. | VSP_018839 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 225 | 1 | M → I. Ref.31 | VAR_040639 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 272 | 1 | R → C. Ref.31 | VAR_040640 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 276 | 1 | W → C. Ref.31 | VAR_040641 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 289 | 1 | G → E in a colorectal cancer sample; somatic mutation. Ref.30 | VAR_035628 | |||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 398 | 1 | S → A. Ref.31 | VAR_040642 | |||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 167 | 1 | K → N: Greatly reduces activity. Greatly reduces phosphorylation at T-412 and moderately reduces phosphorylation at T-252. Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 394 | 1 | S → A: Loss of activity. Loss of phosphorylation at T-412. Ref.15 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 412 | 1 | T → E: Mimics phosphorylation. Facilitates phosphorylation of T-252 by PDPK1; when associated with E-434; E-441; E-444 and E-447. Mimics phosphorylation. No effect on interaction with PDPK1 and phosphorylation of T-252. Impairs association with the eIF3 complex. Ref.3 Ref.10 Ref.21 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 434 | 1 | S → E: Facilitates phosphorylation of T-252 by PDPK1; when associated with E-412; E-441; E-444 and E-447. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 441 | 1 | S → E: Facilitates phosphorylation of T-252 by PDPK1; when associated with E-412; E-434; E-444 and E-447. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 444 | 1 | T → E: Facilitates phosphorylation of T-252 by PDPK1; when associated with E-412; E-434; E-441 and E-447. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 447 | 1 | S → E: Facilitates phosphorylation of T-252 by PDPK1; when associated with E-412; E-434; E-441 and E-444. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 88 – 90 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 91 – 96 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 105 – 110 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 119 – 125 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 143 – 149 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 158 – 163 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 168 – 173 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 180 – 186 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 192 – 205 | 14 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 209 – 211 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 221 – 223 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 224 – 226 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 232 – 234 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 262 – 265 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 273 – 278 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 282 – 287 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 298 – 307 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 318 – 327 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 332 – 335 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 346 – 348 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 350 – 352 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 357 – 361 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini." Grove J., Bonerjee P., Balasubramanyam A., Coffer P., Price D.J., Avruch J., Woodgett J.R. Mol. Cell. Biol. 11:5541-5550(1991) [PubMed: 1922062] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], ALTERNATIVE INITIATION. |
| [2] | "Molecular cloning and characterization of a novel p70 S6 kinase, p70 S6 kinase beta containing a proline-rich region." Gout I., Minami T., Hara K., Tsujishita Y., Filonenko V., Waterfield M.D., Yonezawa K. J. Biol. Chem. 273:30061-30064(1998) [PubMed: 9804755] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [3] | "Phosphorylation and activation of p70s6k by PDK1." Pullen N., Dennis P.B., Andjelkovic M., Dufner A., Kozma S.C., Hemmings B.A., Thomas G. Science 279:707-710(1998) [PubMed: 9445476] [Abstract] Cited for: ENZYME REGULATION, PHOSPHORYLATION AT THR-252, MUTAGENESIS OF THR-412; SER-434; SER-441; THR-444 AND SER-447. |
| [4] | "Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase." Wang X., Li W., Williams M., Terada N., Alessi D.R., Proud C.G. EMBO J. 20:4370-4379(2001) [PubMed: 11500364] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF EEF2K, FUNCTION IN TRANSLATION REGULATION. |
| [5] | "Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action." Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., Tokunaga C., Avruch J., Yonezawa K. Cell 110:177-189(2002) [PubMed: 12150926] [Abstract] Cited for: INTERACTION WITH RPTOR. |
| [6] | "Tumor necrosis factor receptor-associated factor (TRAF) 4 is a new binding partner for the p70S6 serine/threonine kinase." Fleckenstein D.S., Dirks W.G., Drexler H.G., Quentmeier H. Leuk. Res. 27:687-694(2003) [PubMed: 12801526] [Abstract] Cited for: FUNCTION, INTERACTION WITH TRAF4. |
| [7] | "SKAR is a specific target of S6 kinase 1 in cell growth control." Richardson C.J., Broenstrup M., Fingar D.C., Julich K., Ballif B.A., Gygi S., Blenis J. Curr. Biol. 14:1540-1549(2004) [PubMed: 15341740] [Abstract] Cited for: FUNCTION, INTERACTION WITH POLDIP3. |
| [8] | "Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases." Raught B., Peiretti F., Gingras A.C., Livingstone M., Shahbazian D., Mayeur G.L., Polakiewicz R.D., Sonenberg N., Hershey J.W. EMBO J. 23:1761-1769(2004) [PubMed: 15071500] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF EIF4B. |
| [9] | "mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E." Fingar D.C., Richardson C.J., Tee A.R., Cheatham L., Tsou C., Blenis J. Mol. Cell. Biol. 24:200-216(2004) [PubMed: 14673156] [Abstract] Cited for: FUNCTION IN CELL CYCLE PROGRESSION. |
| [10] | "mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events." Holz M.K., Ballif B.A., Gygi S.P., Blenis J. Cell 123:569-580(2005) [PubMed: 16286006] [Abstract] Cited for: FUNCTION IN TRANSLATION INITIATION, INTERACTION WITH EIF3B AND EIF3C, MUTAGENESIS OF THR-412. |
| [11] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; THR-444 AND SER-447, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt." Zhang H.H., Lipovsky A.I., Dibble C.C., Sahin M., Manning B.D. Mol. Cell 24:185-197(2006) [PubMed: 17052453] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF GSK3B. |
| [13] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-447, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth." Dorrello N.V., Peschiaroli A., Guardavaccaro D., Colburn N.H., Sherman N.E., Pagano M. Science 314:467-471(2006) [PubMed: 17053147] [Abstract] Cited for: FUNCTION. |
| [15] | "Mechanism for activation of the growth factor-activated AGC kinases by turn motif phosphorylation." Hauge C., Antal T.L., Hirschberg D., Doehn U., Thorup K., Idrissova L., Hansen K., Jensen O.N., Jorgensen T.J., Biondi R.M., Frodin M. EMBO J. 26:2251-2261(2007) [PubMed: 17446865] [Abstract] Cited for: ENZYME REGULATION, MUTAGENESIS OF LYS-167 AND SER-394. |
| [16] | "S6K1-mediated disassembly of mitochondrial URI/PP1gamma complexes activates a negative feedback program that counters S6K1 survival signaling." Djouder N., Metzler S.C., Schmidt A., Wirbelauer C., Gstaiger M., Aebersold R., Hess D., Krek W. Mol. Cell 28:28-40(2007) [PubMed: 17936702] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF RMP, SUBCELLULAR LOCATION. |
| [17] | "mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)." Garcia-Martinez J.M., Alessi D.R. Biochem. J. 416:375-385(2008) [PubMed: 18925875] [Abstract] Cited for: PHOSPHORYLATION AT THR-412. |
| [18] | "S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2." Zhang J., Gao Z., Yin J., Quon M.J., Ye J. J. Biol. Chem. 283:35375-35382(2008) [PubMed: 18952604] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF IRS1, FUNCTION IN GLUCOSE HOMEOSTASIS, INTERACTION WITH IRS1. |
| [19] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; THR-444 AND SER-447, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [20] | "Regulation and localization of ribosomal protein S6 kinase 1 isoforms." Kim D., Akcakanat A., Singh G., Sharma C., Meric-Bernstam F. Growth Factors 27:12-21(2009) [PubMed: 19085255] [Abstract] Cited for: FUNCTION, ALTERNATIVE SPLICING, PHOSPHORYLATION AT SER-394; THR-412; THR-444 AND SER-447, SUBCELLULAR LOCATION. |
| [21] | "Mechanism of PDK1-catalyzed Thr-229 phosphorylation of the S6K1 protein kinase." Keshwani M.M., Gao X., Harris T.K. J. Biol. Chem. 284:22611-22624(2009) [PubMed: 19570988] [Abstract] Cited for: ENZYME REGULATION, MUTAGENESIS OF THR-412. |
| [22] | "Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1." Dibble C.C., Asara J.M., Manning B.D. Mol. Cell. Biol. 29:5657-5670(2009) [PubMed: 19720745] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF RICTOR. |
| [23] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; THR-444 AND SER-447, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [24] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed: 19608861] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-304, MASS SPECTROMETRY. |
| [25] | "mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling." Julien L.A., Carriere A., Moreau J., Roux P.P. Mol. Cell. Biol. 30:908-921(2010) [PubMed: 19995915] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF RICTOR. |
| [26] | "Rictor is a novel target of p70 S6 kinase-1." Treins C., Warne P.H., Magnuson M.A., Pende M., Downward J. Oncogene 29:1003-1016(2010) [PubMed: 19935711] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF RICTOR. |
| [27] | "Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function." Jastrzebski K., Hannan K.M., Tchoubrieva E.B., Hannan R.D., Pearson R.B. Growth Factors 25:209-226(2007) [PubMed: 18092230] [Abstract] Cited for: REVIEW ON FUNCTION, REVIEW ON ENZYME REGULATION. |
| [28] | "Functions and regulation of the 70kDa ribosomal S6 kinases." Fenton T.R., Gout I.T. Int. J. Biochem. Cell Biol. 43:47-59(2011) [PubMed: 20932932] [Abstract] Cited for: REVIEW ON FUNCTION, REVIEW ON ENZYME REGULATION. |
| [29] | "Structural basis of human p70 ribosomal S6 kinase-1 regulation by activation loop phosphorylation." Sunami T., Byrne N., Diehl R.E., Funabashi K., Hall D.L., Ikuta M., Patel S.B., Shipman J.M., Smith R.F., Takahashi I., Zugay-Murphy J., Iwasawa Y., Lumb K.J., Munshi S.K., Sharma S. J. Biol. Chem. 285:4587-4594(2010) [PubMed: 19864428] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 75-399, PHOSPHORYLATION AT THR-252. |
| [30] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed: 16959974] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] GLU-289. |
| [31] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed: 17344846] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] ILE-225; CYS-272; CYS-276 AND ALA-398. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M60724 mRNA. Translation: AAA36410.1. M60725 mRNA. Translation: AAA36411.1. | ||||||||||||||||||||||||
| IPI | IPI00216132. IPI00759649. | ||||||||||||||||||||||||
| PIR | A41687. | ||||||||||||||||||||||||
| RefSeq | NP_003152.1. NM_003161.2. | ||||||||||||||||||||||||
| UniGene | Hs.463642. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | P23443. | ||||||||||||||||||||||||
| SMR | P23443. Positions 85-414. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| DIP | DIP-29986N. | ||||||||||||||||||||||||
| IntAct | P23443. 6 interactions. | ||||||||||||||||||||||||
| MINT | MINT-203709. | ||||||||||||||||||||||||
| STRING | P23443. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | P23443. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 54041234. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PRIDE | P23443. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000225577; ENSP00000225577; ENSG00000108443. | ||||||||||||||||||||||||
| GeneID | 6198. | ||||||||||||||||||||||||
| KEGG | hsa:6198. | ||||||||||||||||||||||||
| UCSC | uc002ixy.1. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 6198. | ||||||||||||||||||||||||
| GeneCards | GC17P057970. | ||||||||||||||||||||||||
| H-InvDB | HIX0014049. | ||||||||||||||||||||||||
| HGNC | HGNC:10436. RPS6KB1. | ||||||||||||||||||||||||
| HPA | CAB003838. CAB018346. | ||||||||||||||||||||||||
| MIM | 608938. gene. | ||||||||||||||||||||||||
| neXtProt | NX_P23443. | ||||||||||||||||||||||||
| PharmGKB | PA34851. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | prNOG13558. | ||||||||||||||||||||||||
| GeneTree | ENSGT00600000084335. | ||||||||||||||||||||||||
| HOGENOM | HBG755340. | ||||||||||||||||||||||||
| HOVERGEN | HBG108317. | ||||||||||||||||||||||||
| InParanoid | P23443. | ||||||||||||||||||||||||
| OMA | DELEEGX. | ||||||||||||||||||||||||
| OrthoDB | EOG4Q2DFF. | ||||||||||||||||||||||||
| PhylomeDB | P23443. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| BRENDA | 2.7.11.1. 2681. | ||||||||||||||||||||||||
| Pathway_Interaction_DB | a6b1_a6b4_integrin_pathway. a6b1 and a6b4 Integrin signaling. angiopoietinreceptor_pathway. Angiopoietin receptor Tie2-mediated signaling. igf1_pathway. IGF1 pathway. il2_pi3kpathway. IL2 signaling events mediated by PI3K. il4_2pathway. IL4-mediated signaling events. insulin_pathway. Insulin Pathway. avb3_integrin_pathway. Integrins in angiogenesis. mtor_4pathway. mTOR signaling pathway. telomerasepathway. Regulation of Telomerase. rxr_vdr_pathway. RXR and RAR hetrodimerization with other nuclear receptor. met_pathway. Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met). kitpathway. Signaling events mediated by Stem cell factor receptor (c-Kit). tgfbrpathway. TGF-beta receptor signaling. | ||||||||||||||||||||||||
| Reactome | REACT_111102. Signal Transduction. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | P23443. | ||||||||||||||||||||||||
| Bgee | P23443. | ||||||||||||||||||||||||
| CleanEx | HS_RPS6KB1. | ||||||||||||||||||||||||
| Genevestigator | P23443. | ||||||||||||||||||||||||
| GermOnline | ENSG00000108443. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR000961. AGC-kinase_C. IPR011009. Kinase-like_dom. IPR017892. Pkinase_C. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR016238. Ribosomal_S6_kinase. IPR017442. Se/Thr_kinase-like_dom. IPR008271. Ser/Thr_kinase_AS. IPR002290. Ser/Thr_kinase_dom. [Graphical view] | ||||||||||||||||||||||||
| KO | K04688. | ||||||||||||||||||||||||
| Pfam | PF00069. Pkinase. 1 hit. PF00433. Pkinase_C. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PIRSF | PIRSF000605. Ribsml_S6_kin_1. 1 hit. | ||||||||||||||||||||||||
| SMART | SM00133. S_TK_X. 1 hit. SM00220. S_TKc. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| SUPFAM | SSF56112. Kinase_like. 1 hit. | ||||||||||||||||||||||||
| PROSITE | PS51285. AGC_KINASE_CTER. 1 hit. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| NextBio | 24073. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | KS6B1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P23443 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with